Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03207854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Apr 12, 2026 to Dec 31, 2026
    • Enrollment target: 500 to 625
    • Study completion date: Apr 12, 2027 to Dec 31, 2027
    • Site contact updated
    v10
  2. Primary completion date: Apr 12, 2025 to Apr 12, 2026
    • Study completion date: Apr 12, 2026 to Apr 12, 2027
    v9
  3. Primary completion date: Apr 12, 2024 to Apr 12, 2025
    • Study completion date: Apr 12, 2025 to Apr 12, 2026
    v8
  4. Re-verified, no change to tracked fieldsv7
  5. Primary completion date: Apr 12, 2022 to Apr 12, 2024
    • Study completion date: Apr 12, 2023 to Apr 12, 2025
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. 3 versions Re-verified since Sep 18, 2018, no change to tracked fieldsv3-v5
  2. Site contact updatedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study the immune system in a variety of different types of experiments, as well as associated clinical data as appropriate, focused on understanding mechanisms of immunotherapy.
Trial Details
NCT Number NCT03207854
Lead Sponsor University of Southern California
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Healthy Subject, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder, Malignant Neoplasm
Related terms Hematologic Diseases, Hematologic Neoplasms, Immune System Diseases, Neoplasms
Enrollment 625 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov